See more : Morningstar Japan K.K. (4765.T) Income Statement Analysis – Financial Results
Complete financial analysis of Healwell AI Inc. (HWAIF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Healwell AI Inc., a leading company in the industry within the sector.
You may be interested
- Gafisa S.A. (GFSA3.SA) Income Statement Analysis – Financial Results
- Personal Group Holdings Plc (PGH.L) Income Statement Analysis – Financial Results
- GFL Limited (GFLLIMITED.BO) Income Statement Analysis – Financial Results
- InterPrivate IV InfraTech Partners Inc. (IPVIW) Income Statement Analysis – Financial Results
- Shenzhen S.C New Energy Technology Corporation (300724.SZ) Income Statement Analysis – Financial Results
Healwell AI Inc. (HWAIF)
Website: https://www.healwell.ai
About Healwell AI Inc.
Healwell AI Inc., a healthcare technology company, focuses on AI and data science for preventative care. It offers AI-enabled decision support platform for healthcare providers. Healwell AI Inc. has a strategic alliance agreement with WELL Health Technologies Corp to enhance the growth and development of AI-enabled healthcare technologies. The company was formerly known as MCI Onehealth Technologies Inc. and changed its name to Healwell AI Inc. in October 2023. Healwell AI Inc. was incorporated in 2012 and is headquartered in Toronto, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 7.32M | 10.42M | 47.82M | 38.57M | 46.29M |
| Cost of Revenue | 6.06M | 6.71M | 32.81M | -25.65M | 31.03M |
| Gross Profit | 1.26M | 3.71M | 15.01M | 64.22M | 15.26M |
| Gross Profit Ratio | 17.18% | 35.59% | 31.39% | 166.49% | 32.97% |
| Research & Development | 4.81M | 8.14M | 155.00K | 0.00 | 0.00 |
| General & Administrative | 9.06M | 11.36M | 30.18M | 13.61M | 13.53M |
| Selling & Marketing | 1.28M | 1.52M | 1.12M | 125.00K | 0.00 |
| SG&A | 14.04M | 12.88M | 31.30M | 13.74M | 13.53M |
| Other Expenses | 0.00 | 194.00K | 28.00K | 19.00K | 1.87M |
| Operating Expenses | 18.85M | 21.03M | 31.45M | 13.74M | 16.55M |
| Cost & Expenses | 24.91M | 27.74M | 64.26M | -11.91M | 47.58M |
| Interest Income | 0.00 | 20.00K | 109.00K | 64.00K | 76.00K |
| Interest Expense | 0.00 | 618.00K | 462.00K | 497.00K | 536.00K |
| Depreciation & Amortization | 1.48M | 2.54M | 4.31M | 2.96M | 3.12M |
| EBITDA | -16.11M | -15.01M | -11.52M | 2.11M | 3.63M |
| EBITDA Ratio | -220.21% | -143.98% | -25.36% | 5.48% | 7.87% |
| Operating Income | -17.59M | -17.55M | -16.43M | -842.00K | 523.00K |
| Operating Income Ratio | -240.43% | -168.34% | -34.37% | -2.18% | 1.13% |
| Total Other Income/Expenses | -15.09M | 1.13M | 1.85M | 19.00K | -1.45M |
| Income Before Tax | -32.68M | -17.08M | -16.29M | -1.34M | -30.00K |
| Income Before Tax Ratio | -446.67% | -163.81% | -34.06% | -3.47% | -0.06% |
| Income Tax Expense | 542.00K | 1.12M | -747.00K | -312.00K | 91.00K |
| Net Income | -31.60M | -21.09M | -15.67M | -1.03M | -122.00K |
| Net Income Ratio | -431.83% | -202.27% | -32.77% | -2.67% | -0.26% |
| EPS | -0.56 | -0.42 | -0.33 | -0.03 | 0.00 |
| EPS Diluted | -0.56 | -0.42 | -0.33 | -0.03 | 0.00 |
| Weighted Avg Shares Out | 57.03M | 50.08M | 48.00M | 38.33M | 38.01M |
| Weighted Avg Shares Out (Dil) | 57.03M | 50.08M | 48.00M | 38.33M | 38.00M |
WELL Health Launches its AI-POWERED Co-pilot for Cardiologists powered by HEALWELL AI to Help Improve Detection of Cardiovascular Disease
WELL has launched its new AI-powered physician co-pilot to assist cardiologists in better identifying patients at high risk of cardiovascular disease ("CVD"). WELL is exclusively partnering with HEALWELL AI, a leader in AI enabled disease diagnosis, as an extension of...
WELL Health Launches its AI-powered Co-pilot for Cardiologists powered by HEALWELL AI to Help Improve Detection of Cardiovascular Disease
WELL has launched its new AI-powered physician co-pilot to assist cardiologists in better identifying patients at high risk of cardiovascular disease ("CVD"). WELL is exclusively partnering with HEALWELL AI, a leader in AI enabled disease diagnosis, as an extension of...
WELL Health Announces Approval for Historic $44M Project, the Largest DIGITAL Project Ever Awarded to Advance AI-powered Tech Enablement for Care Providers
WELL Health and its consortium partners have been awarded the largest DIGITAL project to date for Health Compass II, an initiative that will continue the advancement of AI and interoperability in Canadian healthcare. WELL Health will not only serve as...
HEALWELL Provides Corporate Update Reflecting Strengthened Balance Sheet with $15.5 Million Reduction of Total Liabilities
HEALWELL is pleased to provide an update on its improved balance sheet with the reduction of approximately $15.5 million of liabilities in Q2-2024. HEALWELL has successfully settled certain payment obligations related to the legacy MCI Medical Clinics Inc. ("MCI Ontario")...
HEALWELL AI Announces Successful Closing of Two Strategic Acquisitions: VeroSource Solutions and BioPharma Services
HEALWELL has completed the previously announced acquisitions of both VeroSource Solutions Inc. and BioPharma Services Inc., which boosts HEALWELL's proforma annualized revenue run-rate to be greater than $65 million and significantly improves HEALWELL's profitability. Serving five different provincial health clients...
HEALWELL AI Announces Strategic Investment in xAI to Accelerate Development of Healthcare Focused Large Language Models That Benefit from xAI Developer Ecosystem
HEALWELL completes USD $2,000,000 strategic investment into an xAI investment vehicle as part of its capital allocation strategy where it seeks to enhance and accelerate the development of its healthcare focused data science capabilities by partnering with world class platforms...
HEALWELL AI Announces Voting Results of 2024 Annual General Meeting of its Shareholders
Toronto, Ontario--(Newsfile Corp. - June 25, 2024) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare technology company focused on AI and data science for preventative care, is pleased to announce the voting results from...
HEALWELL AI's Pentavere Demonstrates Its DARWEN AI System Can Support Earlier Detection of Radiation Related Toxicities in Cancer Patients for Preventative Care
Pentavere collaborated with Princess Margaret Cancer Centre's Radiation Oncology Department to assess the feasibility and accuracy of DARWEN™ AI to find patients experiencing radiation related toxicities based on information retrieved from electronic health records. The data and results from this...
HEALWELL AI to Acquire BioPharma, One of Canada's Largest CROs, to Expand and AI-Enable Clinical Research Offerings
HEALWELL has entered into an agreement to acquire BioPharma Services Inc., one of the largest full-service Contract Research Organizations ("CRO") headquartered in Canada. BioPharma is focused on bioequivalence and early-stage clinical trials, with over 2,200 clinical trials completed to date...
HEALWELL AI to Acquire VeroSource Solutions and its Cloud-based Health Data Interoperability Platform to Help Large Enterprises Adopt AI-Powered Population Health Capabilities
HEALWELL enters into an agreement to acquire VeroSource Solutions Inc. and its end-to-end, customizable, cloud-based platform that enables patients, care providers and administrators to seamlessly access and interact with healthcare data. VeroSource currently serves five provincial health clients and is...
Source: https://incomestatements.info
Category: Stock Reports